Keytruda Overdosage



Merck Sharp & Dohme


Merck Sharp & Dohme
Full Prescribing Info
There is no information on overdosage with Pembrolizumab (KEYTRUDA). The maximum tolerated dose of Pembrolizumab (KEYTRUDA) has not been determined. In clinical trials, patients received up to 10 mg/kg with a similar safety profile to that seen in patients receiving 2 mg/kg.
In case of overdose, patients must be closely monitored for signs or symptoms of adverse reactions, and appropriate symptomatic treatment instituted.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in